On the contrary, Br-MSCs + EXO, EXOs, and Br-MSC-treated groups showed more significant upregulation in the mean value of renal Beclin-1 either gene or protein expression than the nephropathy and CM-treated groups, harmoniously (Figure 7A,E–H). This evidence concerns the gene BECN1 and kidney disorder.